维普期刊资源整合服务平台（V6.5）

262篇 您的检索式：作者名="WACHTELL K"

选中清除导出查看参考文献查看引证文献引用追踪共14页首页上一页第1页下一页末页 /14 跳转

	题名	作者	年代	出处	被引量
1	Reduction in albuminuri a translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study显示文摘	Ibsen H Olsen MH Wachtell K	2005	Hypertension2005，45，：	1
2	Left ventricular filling patterns inpatients with systemic hypertension and left ventricular hypertrophy(the LIFE study)显示文摘	Wachtell K Smith G Gerdts E	2007	Am J Cardiol2007，85，4：	1
3	Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study 显示文摘	Wachtell K Okin PM Olsen MH	2007	Circulation2007，116，7：	1
4	Angiotensin Ⅱ receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End Point Reduction in Hypertension ( LIFE ) Study 显示文摘	Wachtell K Lehto M C erdts E	2005	J Am Coll Cardiol2005，45，：	1
5	Angiotensin Ⅱ receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol:the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study显示文摘	Wachtell K LehtoM Gerdts E		0，，：	1
6	Regression of electro-cardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE study 显示文摘	Wachtell K Ok in PM Olsen MH	2007	Circulation2007，116，7：	1
7	Left ventricular filling patterns inpatient s with systemic hypert ension and left ventricular hypertrophy (the LIFE study) 显示文摘	Wachtell K Smith G Gerdts E	2000	Am J Cardiol2000，85，4：	1
8	Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study显示文摘	Wachtell K Hornestam B Lehto M	2005	J Am Coil Cardiol2005，45，：	1
9	Angiotensin D receptor blockadereduces new-onset atrial fibrillation and subsequent stroke compared toatenolol : the Losartan Intervention For End Point Reduction in Hyper-tension ( LIFE) study显示文摘	Wachtell K Lehto M Gerdts E	2005	Am Coll Cardiol2005，45，5：	1
10	Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study显示文摘	Wachtell K Lehto M Gerdts E	2005	J Am Coll Cardiol2005，45，5：	1
11	Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol , the losartan intervention for end point reduction in hypertension (LIFE) study 显示文摘	Wachtell K Lehto M Gerdts E	2005	J Am Coll Cardiol2005，45，5：	1
12	Ansiotensin II repmr block- ade reduces new - onset atrial fibrillation and subsequent stroke compared to atenoloh the Los&rtan Intervention For End Point Reduction in Hypertension ( LIFE ) study 显示文摘	Wachtell K Lehto M Gents E	2005	J Am Coil Cardiol2005，45，5：	1
13	Change in systolic left ventricular performance after 3 years of antihypertensive treatment, the Losartan intervention for endpoint (LIFE) study显示文摘	Wachtell K Palmieri V Olsen MH	2002	Circulation2002，106，：	1
14	Angiotensin Ⅱ receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the losartan intervention for end point reduction in hypertension (life) study显示文摘	WACHTELL K LEHTO M GERDTS E	2005	J Am Coil Cardiol2005，45，5：	1
15	Albuminuria prediets cardiovas- cular events independently of left ventricular mass in hypertension: a LIFE substudy显示文摘	Olsen MH Wachtell K Bella JN	2004	J Hum Hypertens2004，18，6：	1
16	Angiotensin Ⅱ receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolohthe losartan intervention for end point reduction in hypertension(LIFE) study显示文摘	Wachtell K Lehto M Gerdts E	2005	J Am Coll Cardiol2005，45，5：	1
17	Regression of electurocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension显示文摘	Okin PM Wachtell K Deverux RB	2006	Jam a2006，296，10：	1
18	Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study显示文摘	WACHTELL K LEHTO M GERDTS E	2005	J Am Coll Cardiol2005，45，：	1
19	Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study显示文摘	Wachtell K Okin PM Olsen MH	2007	Circulation2007，116，7：	1
20	Intreatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy:The LIFE Study显示文摘	Wachtell K Gerdts E Aurigemma GP	2010	Blood Press2010，19，3：	1

返回顶部每页显示：

共14页首页上一页第1页下一页末页 /14 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示